Alimera Sciences, Inc. (ALIM Quick QuoteALIM - Free Report) was a big mover last session, as the company saw its shares rise almost 13% on the day. The upside was driven by the company’s improved fourth-quarter and full-year 2016 results. This continues the recent uptrend for the company as the stock is now up 33.61% in the past one-month time frame.

The company has seen no positive or negative estimate revision in the past 30 days. Also, its Zacks Consensus Estimate remained unchanged over the same timeframe. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Alimera Sciences currently carries a Zacks Rank #3 (Hold).
 

Alimera Sciences, Inc. Price

 

Alimera Sciences, Inc. Price | Alimera Sciences, Inc. Quote

A better-ranked stock in the Medical-Biomedical and Genetics industry is Heska Corporation , which sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is ALIM going up? Or down? Predict to see what others think: Up or Down

Zacks' 2017 IPO Watch List

Before looking into the stocks mentioned above, you may want to get a head start on potential tech IPOs that are popping up on Zacks' radar. Imagine being in the first wave of investors to jump on a company with almost unlimited growth potential? This Special Report gives you the current scoop on 5 that may go public at any time.

One has driven from 0 to a $68 billion valuation in 8 years. Four others are a little less obvious but already show jaw-dropping growth. Download this IPO Watch List today for free >>